AC Immune (ACIU) Total Liabilities (2014 - 2026)

AC Immune (ACIU) has 13 years of Total Liabilities data on file, last reported at $135.2 billion in Q1 2026.

• Total Liabilities for Q1 2026 came in at $135.2 billion, up 104447.23% year-over-year; the trailing twelve-month figure through Mar 2026 was $135.2 billion (up 104447.23% YoY), and the FY2025 annual result was $131.9 million, down 2.6% from the prior year.
• Total Liabilities improved to $135.2 billion in Q1 2026 per ACIU's latest filing, from $136.8 million in the prior quarter.
• Over five years, Total Liabilities peaked at $135.2 billion in Q1 2026 and troughed at $14.5 million in Q2 2022.
• A 5-year average of $8.0 billion and a median of $25.9 million in 2024 frame the typical range for Total Liabilities.
• The sharpest annual moves came in 2022 and 2026: Total Liabilities plunged 44.95% in 2022, then jumped 104447.23% in 2026.
• A 5-year view of Total Liabilities shows it stood at $17.6 million in 2022, then jumped by 42.08% to $25.0 million in 2023, then surged by 441.85% to $135.4 million in 2024, then climbed by 1.04% to $136.8 million in 2025, then soared by 98717.21% to $135.2 billion in 2026.
• Business Quant data shows ACIU's Total Liabilities at $135.2 billion in Q1 2026, $136.8 million in Q4 2025, and $136.5 million in Q3 2025.